Overview

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Status:
Completed
Trial end date:
2017-09-05
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and efficacy of once-daily application of CLS001 topical gel compared to vehicle gel in subjects with severe papulopustular rosacea.
Phase:
Phase 3
Details
Lead Sponsor:
Cutanea Life Sciences, Inc.
Maruho Co., Ltd.